FKnol.com

Financial Knowledge & Information Portal

Abbott Labs (ABT) Company Profile

Updated Jun 19, 2020
Abbott Labs has the following business profile:
Company's Full Name:Abbott Laboratories
Short Name:Abbott Labs
Trading Ticker Symbol:ABT
Primary Exchange:NYSE
Headquarter City/Country:North Chicago, Illinois
Primary Industry Sector:Health Care
Seconday Sub-sector:Major Pharmaceuticals
Main Business Areas: Health Care, Major Pharmaceuticals, Medical Devices, Pharma, Healthcare, Dividend Aristocrats, S&P 500, Marijuana, Cannabis
Dividend Payments:Dividend History
Technical Analysis:Recent Candlestick Patterns
ETFs Holding:List of ETFs holding Abbott Labs stock

Market and Trading Information for Abbott Labs

The following details were available for trading and market data about the stock of Abbott Labs as of writing:
Current Share Price:$90.68
Previous Year's Closing Price:$86.86
Percentage Price Change (YTD):4.4%
Market Cap:$160.4 billion
52-week Price Range:$61.61 - $100
Dividend Per Share:$1.32
EPS (TTM):1.99
Price-Earnings (Trailing):45.54
Price-Earnings (Forward):24.71

Company Profile and Business Description for Abbott Labs

Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Company, through St. Jude Medical, Inc., also offers a range of products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

The principal products in the Company's other businesses include blood glucose and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes, under the FreeStyle brand, and medical devices for the eye, including cataract surgery, laser-assisted in situ keratomileusis (LASIK) surgery, contact lens care products and dry eye products. These products are marketed around the world and sold to wholesalers, government agencies, private healthcare organizations, healthcare facilities, mail order pharmacies, and independent retailers from its distribution centers and public warehouses.

Established Pharmaceutical Products

The Company's Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. These products are sold directly to wholesalers, distributors, government agencies, healthcare facilities, pharmacies, and independent retailers from its distribution centers and public warehouses, depending on the market served. The principal products included in the therapeutic area of the Established Pharmaceutical Products segment are gastroenterology products, women's health products, cardiovascular and metabolic products, pain and central nervous system products, and respiratory drugs and vaccines.

The gastroenterology products include Creon, which is used for the treatment of pancreatic exocrine insufficiency associated with various underlying conditions, including cystic fibrosis and chronic pancreatitis; Duspatal and Dicetel, which is used for the treatment of irritable bowel syndrome or biliary spasm; Heptral, Transmetil and Samyr, which is used for the treatment of intrahepatic cholestasis (associated with liver disease) or depressive symptoms, and Duphalac, which is used for regulation of the physiological rhythm of the colon. Its women's health products include Duphaston, which is used for the treatment of various gynecological disorders, and Femoston, which is a hormone replacement therapy for postmenopausal women.

The cardiovascular and metabolic products include Lipanthyl and TriCor, which is used for the treatment of dyslipidemia; Teveten and Teveten Plus, which is used for the treatment of essential hypertension; Physiotens, which is used for the treatment of hypertension, and Synthroid, which is used for the treatment of hypothyroidism. Its pain and central nervous system products include Serc, which is used for the treatment of Meniere's disease and vestibular vertigo; Brufen, which is used for the treatment of pain, fever and inflammation, and Sevedol, for the treatment of severe migraines. Its respiratory drugs and vaccines include the anti-infective clarithromycin, which are sold under the brands Biaxin, Klacid, and Klaricid, and Influvac, which is an influenza vaccine.

Diagnostic Products

The Company's Diagnostic Products include a range of diagnostic systems and tests manufactured, marketed, and sold around the world. These products are marketed and sold to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate care testing sites and plasma protein therapeutic companies from its distribution centers, public warehouses or third party distributors. The principal products in the Diagnostic Products segment include immunoassay and clinical chemistry systems, including ARCHITECT, ABBOTT PRISM, and the Alinity family of instruments, with assays used for screening and/or diagnosis for cancer, cardiac, metabolics, drugs of abuse, fertility, general chemistries, infectious diseases, such as hepatitis and human immunodeficiency virus (HIV), and therapeutic drug monitoring; a range of hematology systems and reagents known as the Cell-Dyn series; the i-STAT and i-STAT Alinity point-of-care diagnostic systems and cartridges for blood analysis; m2000, which is an instrument that automates the extraction, purification, and preparation of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from patient samples, and detects and measures infectious agents; the Vysis FISH product line of genomic-based tests, including the PathVysion Human Epidermal Growth Factor Receptor 2 (HER-2) DNA probe kit, the UroVysion bladder cancer recurrence kit, and the Vysis ALK Break Apart FISH Probe Kit, and informatics and automation solutions for use in laboratories, including ACCELERATOR a3600, and AlinIQ, a range of informatics tools and professional services.

Nutritional Products

The Company's Nutritional Products include a range of pediatric and adult nutritional products manufactured, marketed and sold around the world. These products are marketed and sold to consumers and to institutions, wholesalers, retailers, healthcare facilities, government agencies, and third-party distributors from its distribution centers or third-party distributors. The products in the Nutritional Products segment include various forms of prepared infant formula and follow-on formula, including Similac, Similac Pro-Advance, Similac Advance, Similac Pro-Sensitive, Similac Sensitive, Go&Grow by Similac, Similac NeoSure, Similac Organic, Similac Special Care, Similac Total Comfort, Similac For Supplementation, Isomil Advance, Similac Qinti and Eleva; adult and other pediatric nutritional products, including Ensure, Ensure Plus, Ensure Enlive, Ensure Complete, Ensure High Protein, Glucerna, Glucerna Hunger Smart, ProSure, PediaSure, PediaSure Sidekicks, PediaSure Peptide, EleCare, Juven, Abound and Pedialyte; nutritional products, which are used in enteral feeding in healthcare institutions, including Jevity, Osmolite, Oxepa, Freego (Enteral Pump) and Freego sets, Nepro, and Vital, and Zone Perfect bars and the EAS family of nutritional brands, including Myoplex and AdvantEdge.

Vascular Products

The Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease that are manufactured, marketed and sold around the world. In the United States, these products are marketed and sold to hospitals from its distribution centers and public warehouses. The products in the Vascular Products segment include the XIENCE family of drug-eluting coronary stent systems developed on the Multi-Link Vision platform; StarClose SE and ProGlide vessel closure devices; TREK coronary balloon dilatation products; Hi-Torque Balance Middleweight Universal and ASAHI coronary guidewires; MitraClip, which is a percutaneous mitral valve repair system; Supera Peripheral Stent System, which is a peripheral vascular stent system, and Acculink/Accunet, and Xact/Emboshield NAV and carotid stent systems.

100 Abbott Park Rd

ETFs Holding Abbott Labs Stock

As of March 2020, the following exchange-traded funds (ETF) hold the Abbott Labs stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Abbott Labs stock holding. There are a total of 162 ETFs in Fknol.com records which are holding Abbott Labs stock in their portfolio. See Full List.

TickerNameShort DescriptionExpense
Ratio
No. of
Holdings
Dividend
Frequency
ACIMSPDR MSCI ACWI IMI ETFThe SPDR MSCI ACWI IMI ETF tracks a market-cap-weighted index of global stocks covering 98% of the capitalization of the developed and emerging markets. ...Full Details0.25%906
Full List
Semi-Annually
ACWIiShares MSCI ACWI ETFThe iShares MSCI ACWI ETF tracks a market-cap-weighted index of large- and midcap global stocks, covering 85% of the developed and emerging markets capitalization. ...Full Details ...Candlestick Patterns.0.32%1596
Full List
Semi-Annually
CHGXChange Finance Diversified Impact US Large Cap Fossil Fuel Free ETFCHGX tracks an index of 100 US large-cap stocks that meet diverse environmental, social, and governance standards. ...Full Details0.49%101
Full List
Annually
CRBNiShares MSCI ACWI Low Carbon Target ETFThe iShares MSCI ACWI Low Carbon Target ETF tracks an index of stocks from global firms selected for a bias toward lower carbon emissions, but with tight constraints to the broad, marketlike ACWI index. ...Full Details0.2%1204
Full List
Semi-Annually
CSMProshares Large Cap Core PlusThe ProShares Large Cap Core Plus ETF tracks a long/short index of the 500 largest US stocks. It uses a set of rules to assign weights to each equity that add up to 130% long and 30% short exposure. ...Full Details0.45%320
Full List
Quarterly
DEFInvesco Defensive Equity ETFThe Invesco Defensive Equity ETF tracks an index that aims to outperform in down markets while maintaining upside potential. The equal-weighted index picks 100 US stocks using proprietary methods. ...Full Details0.6%101
Full List
Annually
DGROiShares Core Dividend Growth ETFThe iShares Core Dividend Growth ETF tracks an index of US stocks that are selected by dividends, dividend growth and payout ratio, then weighted by dividend dollars. ...Full Details0.08%449
Full List
Quarterly
DIVBiShares US Dividend and Buyback ETFThe iShares US Dividend and Buyback ETF tracks an index of large-, mid-, and small-cap US stocks that have a history of dividend payments and/or share buybacks. ...Full Details0.25%354
Full List
Annually
DLNWisdomTree US LargeCap Dividend ETFThe WisdomTree U.S. LargeCap Dividend Fund tracks a dividend-weighted index of the 300 largest US companies that pay regularly pay cash dividends. ...Full Details0.28%294
Full List
Monthly
DTDWisdomTree US Total Dividend ETFThe WisdomTree U.S. Total Dividend Fund tracks an index of U.S. companies selected and weighted based on the dollar amount of dividends paid. ...Full Details0.28%864
Full List
Monthly

See Full List of ETFs holding Abbott Labs stock in their respective portfolios.

Peer / Competitor Companies of Major Pharmaceuticals Sector

Along with Abbott Laboratories, the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Health Care sector whose company profile and dividend history is as follows:

▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile,  Dividend History  and Recent Candlestick Patterns.

▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile,  Dividend History

▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile,  Dividend History

▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile,  Dividend History

▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile,  Dividend History

▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile,  Dividend History

▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile,  Dividend History

▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile,  Dividend History

▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile,  Dividend History

▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile,  Dividend History

▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile,  Dividend History

▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile,  Dividend History

▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile,  Dividend History

▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile,  Dividend History

▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile,  Dividend History

▶ AEterna Zentaris (AEZS): Aeterna Zentaris Inc., incorporated on October 12, 1990, is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and womens health. The Company operates through the ....See Detailed Company Profile,  Dividend History

▶ Affimed (AFMD): Affimed N.V., incorporated on May 1, 2014, is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Companys product candidates are developed in the field of immuno-oncology, ....See Detailed Company Profile,  Dividend History

▶ Agile Therapeutics (AGRX): Agile Therapeutics, Inc., incorporated on December 5, 1997, is a womens health specialty pharmaceutical company. The Company is focused on the development and commercialization of prescription contraceptive products. Its product ....See Detailed Company Profile,  Dividend History

▶ Agios Pharma (AGIO): Agios Pharmaceuticals, Inc., incorporated on August 7, 2007, is a clinical-stage biopharmaceutical company. The Companys therapeutic areas of focus are cancer and rare genetic metabolic disorders, which are a group ....See Detailed Company Profile,  Dividend History

▶ Aimmune Therapeutics (AIMT): Aimmune Therapeutics, Inc., incorporated on June 24, 2011, is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other ....See Detailed Company Profile,  Dividend History

... See Full List of All Stocks of Major Pharmaceuticals Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Biotechnology Sector

▶ Stocks of Diagnostics & Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Drug Manufacturers—Specialty & Generic Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Care Facilities Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Devices Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Instruments & Supplies Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector


Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Discretionary Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Healthcare Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector